Neuroone Medical Technologies (NMTC) Asset Utilization Ratio (2020 - 2026)
Neuroone Medical Technologies filings provide 10 years of Asset Utilization Ratio readings, the most recent being 1.18 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 12.42% to 1.18 in Q1 2026 year-over-year; TTM through Mar 2026 was 1.18, a 12.42% increase, with the full-year FY2025 number at 1.13, up 119.63% from a year prior.
- Asset Utilization Ratio hit 1.18 in Q1 2026 for Neuroone Medical Technologies, up from 0.9 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.18 in Q1 2026 to a low of 0.01 in Q1 2022.
- Median Asset Utilization Ratio over the past 5 years was 0.66 (2024), compared with a mean of 0.53.
- Biggest five-year swings in Asset Utilization Ratio: tumbled 30.1% in 2022 and later surged 1908.19% in 2023.
- Neuroone Medical Technologies' Asset Utilization Ratio stood at 0.02 in 2022, then soared by 1704.59% to 0.4 in 2023, then soared by 139.58% to 0.97 in 2024, then fell by 7.11% to 0.9 in 2025, then surged by 31.34% to 1.18 in 2026.
- The last three reported values for Asset Utilization Ratio were 1.18 (Q1 2026), 0.9 (Q4 2025), and 0.84 (Q3 2025) per Business Quant data.